Activating Voice Journaling for Mental Health With Voice Biomarkers
1 other identifier
observational
50,000
1 country
1
Brief Summary
This retrospective observational study evaluated the relationship between voice characteristics and self-reported mental health symptoms using longitudinal data collected through the Kintsugi Voice Journaling app. Participants provided voice recordings and completed the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) over time. The study analyzed previously collected data to evaluate whether voice biomarkers could be associated with symptoms of depression and anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 12, 2026
CompletedFirst Posted
Study publicly available on registry
August 27, 2026
CompletedAugust 27, 2026
August 1, 2026
2 years
August 12, 2026
August 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association Between Voice Biomarkers and Depressive Symptom Severity (PHQ-9)
Association between voice biomarkers and depressive symptom severity as measured by the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a 9-item self-report measure of depressive symptom severity; each item is scored 0-3 and total scores range from 0 to 27, with higher scores indicating greater (worse) depressive symptom severity.
Through study completion, up to 24 months
Secondary Outcomes (1)
Association Between Voice Biomarkers and Anxiety Symptom Severity (GAD-7)
Through study completion, up to 24 months
Study Arms (1)
Kintsugi Voice Journaling App Users
Individuals who used the Kintsugi Voice Journaling app and contributed voice recordings along with self-reported PHQ-9 and/or GAD-7 assessments during routine use of the application. No intervention was assigned as part of this study; all data were collected previously during routine app use and analyzed retrospectively.
Eligibility Criteria
The study population consisted of users of the Kintsugi Voice Journaling app, a mobile application available globally, who had previously contributed voice recordings and self-reported mental health questionnaire data during routine use of the application. Participants were not recruited at a physical study site; all data were contributed remotely through the app. No participants meeting the inclusion criteria were excluded from the analysis.
You may qualify if:
- Use of the Kintsugi Voice Journaling app during the observation period
- Previously collected voice recording data available from use of the app
- At least one completed PHQ-9 and/or GAD-7 assessment during the observation period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kintsugi Mindful Wellness, Inc.
Berkeley, California, 94707, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Grace Chang
Kintsugi Mindful Wellness, Inc.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2026
First Posted
August 27, 2026
Study Start
October 1, 2019
Primary Completion
October 1, 2021
Study Completion
October 1, 2021
Last Updated
August 27, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared. The dataset consists of voice recordings, which are inherently identifiable and cannot be reliably de-identified, together with associated self-reported mental health assessments.